does glp-1 affect kidneys Glucagon-like peptide 1(GLP-1) receptor agonists in the management of the patient with type 2diabetes mellitus and chronic kidney disease: an approach for the nephrologist From Fat Burn to Muscle

The medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, and is not indicated for type 1 diabetes or use with other GLP-1 receptor agonists

In this process, the renin-angiotensin-aldosterone system (RAAS) is assumed to play a role

Research in aging rats demonstrated that Epithalon treatment significantly increased activities of key antioxidant enzymes including superoxide dismutase (SOD), glutathione peroxidase (GPX), and glutathione-S-transferase

M.BaileyJ

Staying updated on emerging therapies empowers clinical pharmacists to deliver evidence-based, patient-centered care